Venous Leg Ulcer Treatment Market: By Drug Class (Antibiotics, Corticosteroids, Monoclonal Antibodies, Immunosuppressant Drugs, Others), By Route of Administration (Oral, Parenteral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography    

Purchase Option

$ 4400
$ 6600
$ 8900

Venous Leg Ulcer Treatment Market size was valued at USD 2,851.2 million in 2022, It is growing at a CAGR of 5.3% from 2023-2029. Venous leg ulcers are most frequently brought on by infection, although they can also be brought on by diabetes, obesity, and ageing. If left untreated, venous leg ulcers can become exceedingly painful and quickly worsen into more dangerous conditions. Leg ulcers caused by venous blood flow can be treated using a variety of techniques. While some ulcer treatments call for surgery, others call for the use of drugs to aid in ulcer healing. The origin of the ulcer and the patient's symptoms will determine the best course of treatment for venous leg ulcers. The global market provides a detailed overview and can be segmented by drug class, route of administration, distribution channel, and region. By drug class, the market has been segmented into antibiotics, corticosteroids, monoclonal antibodies, immunosuppressant drugs, and others. By route of administration, the market has been segmented into oral, parenteral, and topical. By distribution channel, the venous leg ulcer treatment market has been segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment continues its dominance during the forecast period share in the market owing to the increase in the hospitalization rate and the rise in hospital healthcare infrastructure.

The Venous Leg Ulcer Treatment Market Key Development:
  • In June 2019, Milliken & Company acquired Andover Healthcare, a leading manufacturer of cohesive bandages and compression systems with an aim to provide innovative and comprehensive solutions for patient care.

Global Venous Leg Ulcer Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.3%

Largest Market

North America

Fastest Growing Market

Europe
Venous Leg Ulcer Treatment Market Dynamics

Rising prevalence of venous leg ulcers globally to accelerate market growth worldwide. Apart from this, immobility, varicose veins, obesity, pregnancy, and previous deep vein thrombosis are some other factors that contribute to the development of venous leg ulcers. According to an article published by the national center for biotechnology information (NCBI) in 2010, the prevalence of venous leg ulcers in the U.S. is nearly 600,000 annually. Along with rising awareness among the patient population regarding available treatment options, and the increasing geriatric population is also poised to push the market growth.

Global Venous Leg Ulcer Treatment Market Segmentation

By Drug Class
  • Antibiotics
  • Corticosteroids
  • Monoclonal Antibodies
  • Immunosuppressant Drugs
  • Others
By Route of Administration
  • Oral
  • Parental
  • Topical
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Frequently Asked Questions

The venous leg ulcer treatment market is projected to expand at a CAGR of 5.3% during the forecast period.  

Cardinal Health, Inc. (U.S.), Genentech, Inc. (U.S.), Hoffmann La Roche Ltd. (Switzerland), Leap Therapeutics, Inc. (U.S.), Daval International Ltd. (U.K.)

North America is the fastest-growing region for the venous leg ulcer treatment market

Partnerships and acquisitions opted by leading players in the venous leg ulcer treatment market. Many players such as Integra life sciences, smith & nephew, Coloplast corp., and 3m. introducing innovative treatment options for venous leg ulcers, and expansion of sales channels are key strategies adopted by leading market players to retain their dominating position in the market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market and forecast
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup's details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market
1.Executive Summary
2.Global Venous Leg Ulcer Treatment Market  Introduction 
2.1.Global Venous Leg Ulcer Treatment Market   - Taxonomy
2.2.Global Venous Leg Ulcer Treatment Market   - Definitions
2.2.1.Drug Class
2.2.2.Route of Administration
2.2.3.Distribution Channel
2.2.4.Region
3.Global Venous Leg Ulcer Treatment Market  Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Venous Leg Ulcer Treatment Market  Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Venous Leg Ulcer Treatment Market   By Drug Class, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Antibiotics
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Corticosteroids
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Monoclonal Antibodies
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Immunosuppressant Drugs
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Others
5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6.Global Venous Leg Ulcer Treatment Market   By Route of Administration, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Oral
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Parental
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Topical
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Venous Leg Ulcer Treatment Market   By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Hospital Pharmacies
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Retail Pharmacies
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Online Pharmacies
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Venous Leg Ulcer Treatment Market   By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Venous Leg Ulcer Treatment Market  ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Drug Class Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Antibiotics
9.1.2.Corticosteroids
9.1.3.Monoclonal Antibodies
9.1.4.Immunosuppressant Drugs
9.1.5.Others
9.2.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Oral
9.2.2.Parental
9.2.3.Topical
9.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospital Pharmacies
9.3.2.Retail Pharmacies
9.3.3.Online Pharmacies
9.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Venous Leg Ulcer Treatment Market  ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Antibiotics
10.1.2.Corticosteroids
10.1.3.Monoclonal Antibodies
10.1.4.Immunosuppressant Drugs
10.1.5.Others
10.2.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Oral
10.2.2.Parental
10.2.3.Topical
10.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospital Pharmacies
10.3.2.Retail Pharmacies
10.3.3.Online Pharmacies
10.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
10.4.7.
11.Asia Pacific (APAC) Venous Leg Ulcer Treatment Market  ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Antibiotics
11.1.2.Corticosteroids
11.1.3.Monoclonal Antibodies
11.1.4.Immunosuppressant Drugs
11.1.5.Others
11.2.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Oral
11.2.2.Parental
11.2.3.Topical
11.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospital Pharmacies
11.3.2.Retail Pharmacies
11.3.3.Online Pharmacies
11.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Venous Leg Ulcer Treatment Market  ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Antibiotics
12.1.2.Corticosteroids
12.1.3.Monoclonal Antibodies
12.1.4.Immunosuppressant Drugs
12.1.5.Others
12.2.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Oral
12.2.2.Parental
12.2.3.Topical
12.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospital Pharmacies
12.3.2.Retail Pharmacies
12.3.3.Online Pharmacies
12.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Venous Leg Ulcer Treatment Market  ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Antibiotics
13.1.2.Corticosteroids
13.1.3.Monoclonal Antibodies
13.1.4.Immunosuppressant Drugs
13.1.5.Others
13.2.  Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Oral
13.2.2.Parental
13.2.3.Topical
13.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospital Pharmacies
13.3.2.Retail Pharmacies
13.3.3.Online Pharmacies
13.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Cardinal Health, Inc. (U.S.)
14.2.2.Genentech, Inc. (U.S.)
14.2.3.Hoffmann La Roche Ltd. (Switzerland)
14.2.4.Leap Therapeutics, Inc. (U.S.)
14.2.5.Daval International Ltd. (U.K.)
14.2.6.RegeneRx Biopharmaceuticals, Inc. (U.S.)
14.2.7.MediWound Ltd (Israel)
15. Research Methodology 
16. Appendix and Abbreviations 
  • Cardinal Health, Inc. (U.S.)
  • Genentech, Inc. (U.S.)
  • Hoffmann La Roche Ltd. (Switzerland)
  • Leap Therapeutics, Inc. (U.S.)
  • Daval International Ltd. (U.K.)
  • RegeneRx Biopharmaceuticals, Inc. (U.S.)
  • MediWound Ltd (Israel)

Adjacent Markets